Skip to main content
. 2022 Mar 1;103:103644. doi: 10.1016/j.drugpo.2022.103644

Fig. 2.

Fig. 2

Weekly number of people actively being treated with methadone and buprenorphine/naloxone, June 25, 2019 to November 30, 2020. Note: Counts for the week of June 25th and July 2nd, 2019 appear lower because our study period began on June 25, 2019, and therefore data for people who were actively being treated during the first couple weeks of the study period do not capture individuals who were dispensed OAT prior to the beginning of the study period and had take-home doses that overlapped the beginning of study period.